Telesis Bio Inc
TBIO
Get informed when a big investor buys or sells
+ FollowMarket Cap$783.94K
Close$
$6.67
66579% upside
Current Fair Value
66579% upsideUndervalued by 66579% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $783,935.00 |
|---|---|
| Enterprise Value | $13.35 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-1.59 |
| Beta | 2.43 |
| Outstanding Shares | 1,732,238 |
Return
| Return on Equity | -1175.81% |
|---|---|
| Return on Assets | -184.14% |
| Return on Invested Capital | -157.00% |
Valuation & Multiples
| P/E Ratio | -0.01 |
|---|---|
| PEG | 0.02 |
| Price to Sales | 0.0 |
| Price to Book Ratio | 0.01 |
| Enterprise Value to Revenue | 0.99 |
| Enterprise Value to EBIT | -0.47 |
| Enterprise Value to Net Income | -1 |
| Total Debt to Enterprise | 1.22 |
| Debt to Equity | 4.21 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
May 29, 2026
EPS Estimate
$-6.39
Average shareholder expectationRevenue Estimate
$2.53 M
Average shareholder expectationNext Earnings Call
Expected Date
August 6, 2026
EPS Estimate
$-6.39
Average shareholder expectationRevenue Estimate
$2.53 M
Average shareholder expectationInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data